Your browser doesn't support javascript.
loading
Pathologically Complete Response after Triple Therapy in Locally Advanced Esophageal Cancer in a Hereditary Hemorrhagic Telangiectasia Patient.
Park, Robin; Philp, Alisdair; Nagji, Alykhan S; Kasi, Anup.
Affiliation
  • Park R; Department of Medicine, MetroWest Medical Center, Framingham, Massachusetts, USA.
  • Philp A; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, Kansas, USA.
  • Nagji AS; Department of Cardiovascular and Thoracic Surgery, Kansas University Medical Center, Kansas City, Kansas, USA.
  • Kasi A; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, Kansas, USA.
Case Rep Oncol ; 13(1): 176-181, 2020.
Article in En | MEDLINE | ID: mdl-32231541
ABSTRACT
Hereditary hemorrhagic telangiectasia (HHT) is a disorder characterized by vascular manifestations including mucocutaneous and visceral telangiectasias and arteriovenous malformations. Herein we present the case of a relatively young patient with HHT with an incidentally discovered locally advanced esophageal cancer on endoscopic screening and pathologically complete response after neoadjuvant chemoradiation. This case highlights an unusual tumor response to chemoradiation in locally advanced esophageal cancer, and the surveillance care of HHT patients.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Case Rep Oncol Year: 2020 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Case Rep Oncol Year: 2020 Document type: Article Affiliation country: Estados Unidos